Advertisement

Payer

Following CMS's preliminary decision to limit the coverage of Biogen's Alzehimer's disease treatment Aduhelm, advocates are calling on the agency to broaden its coverage or risk the future of similar drugs, according to a Jan. 17 Politico report. 

Florida Blue parent company GuideWell named Kelli Tice, MD, the company's first chief health equity officer, according to a Jan. 19 news release shared with Becker's. 

Advertisement
Advertisement